The conference will explore the value of biomarkers from both a clinical and commercial perspective. The aim is to help end users to develop a comprehensive strategy for biomarker discovery, development, application, and analysis in clinical trials. Key topics include:

• Biomarker pathway from discovery and development to commercialisation and utilisation
• Epigenetic biomarker development
• Biomarkers in adaptive clinical trials
• Big data innovations in biomarker research
• Reimbursement, regulation and intellectual property for biomarkers